Sign In
to Vote &
Create Storyboards.
 

Drug Deal to Generate Tax Benefits

Wall Street Journal - 19 May 2015 03:13
Endo International agreed to buy Par Pharmaceutical from private-equity firm TPG for about $8 billion in cash and stock.
1
0
0


Storyboard
Print
Share this Article



Comment on this Article

Please Sign In to comment

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard